INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $165,138,323 | -18.5% | 3,170,250 | -1.0% | 2.66% | -8.0% |
Q2 2023 | $202,737,976 | +14.6% | 3,201,800 | -2.0% | 2.89% | +12.6% |
Q1 2023 | $176,962,200 | +0.1% | 3,268,000 | -2.2% | 2.57% | +9.4% |
Q4 2022 | $176,871,129 | +14.2% | 3,342,236 | +0.4% | 2.35% | +5.6% |
Q3 2022 | $154,912,000 | -19.0% | 3,329,279 | -0.6% | 2.22% | -17.8% |
Q2 2022 | $191,183,000 | -8.9% | 3,349,379 | -2.3% | 2.70% | +10.9% |
Q1 2022 | $209,859,000 | +10.5% | 3,429,619 | -5.5% | 2.44% | +24.5% |
Q4 2021 | $189,938,000 | +35.0% | 3,628,919 | -3.8% | 1.96% | +37.1% |
Q3 2021 | $140,691,000 | -4.5% | 3,773,919 | +4.5% | 1.43% | -0.7% |
Q2 2021 | $147,357,000 | +18.7% | 3,609,919 | -1.4% | 1.44% | +9.4% |
Q1 2021 | $124,181,000 | +6.7% | 3,659,919 | 0.0% | 1.31% | -1.4% |
Q4 2020 | $116,386,000 | +26.7% | 3,659,919 | +2.2% | 1.33% | +5.0% |
Q3 2020 | $91,861,000 | -5.3% | 3,579,919 | -5.3% | 1.27% | -7.6% |
Q2 2020 | $97,031,000 | +69.2% | 3,779,919 | +1.3% | 1.37% | +23.5% |
Q1 2020 | $57,358,000 | -29.3% | 3,731,819 | +57.7% | 1.11% | -13.6% |
Q4 2019 | $81,177,000 | +319.7% | 2,366,000 | -8.6% | 1.29% | +257.5% |
Q3 2019 | $19,340,000 | -33.6% | 2,588,990 | +15.3% | 0.36% | -27.7% |
Q2 2019 | $29,147,000 | +4765.9% | 2,245,500 | +4169.0% | 0.50% | +1176.9% |
Q4 2018 | $599,000 | -49.5% | 52,600 | -3.7% | 0.04% | -48.0% |
Q3 2018 | $1,185,000 | -16.1% | 54,600 | -31.7% | 0.08% | -37.5% |
Q2 2018 | $1,412,000 | -26.3% | 79,900 | -12.2% | 0.12% | -36.8% |
Q1 2018 | $1,916,000 | +43.1% | 91,000 | -1.6% | 0.19% | +35.7% |
Q4 2017 | $1,339,000 | +112.2% | 92,500 | +131.2% | 0.14% | +112.1% |
Q3 2017 | $631,000 | +27.0% | 40,000 | 0.0% | 0.07% | +11.9% |
Q2 2017 | $497,000 | – | 40,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |